Primary |
Haemodialysis |
33.3% |
Muscle Spasticity |
33.3% |
Renal Failure Chronic |
33.3% |
|
Unresponsive To Stimuli |
25.0% |
Cardiovascular Disorder |
20.0% |
Cardio-respiratory Arrest |
15.0% |
Adverse Event |
5.0% |
Cardiac Disorder |
5.0% |
Medical Device Complication |
5.0% |
No Therapeutic Response |
5.0% |
Pain |
5.0% |
Restlessness |
5.0% |
Therapy Change |
5.0% |
Vomiting |
5.0% |
|
Secondary |
Breast Cancer |
20.0% |
Evidence Based Treatment |
15.0% |
Drug Use For Unknown Indication |
13.3% |
Product Used For Unknown Indication |
12.5% |
Asthma |
10.0% |
Chronic Obstructive Pulmonary Disease |
4.2% |
Nasal Congestion |
3.3% |
Rhinitis |
3.3% |
Back Pain |
2.5% |
Pain |
2.5% |
Systemic Lupus Erythematosus |
2.5% |
Arthrogram |
1.7% |
Hypertension |
1.7% |
Immunosuppression |
1.7% |
Rheumatoid Arthritis |
1.7% |
Abdominal Pain |
0.8% |
Analgesic Therapy |
0.8% |
Depressed Mood |
0.8% |
Depression |
0.8% |
Gastrointestinal Stromal Tumour |
0.8% |
|
Metastases To Bone |
17.6% |
Swelling |
11.8% |
Inappropriate Antidiuretic Hormone Secretion |
8.8% |
Visual Acuity Reduced |
8.8% |
Infusion Site Extravasation |
5.9% |
Wrong Drug Administered |
5.9% |
Antepartum Haemorrhage |
2.9% |
Clostridium Difficile Colitis |
2.9% |
Drug Administration Error |
2.9% |
Dysphonia |
2.9% |
Gait Disturbance |
2.9% |
Guillain-barre Syndrome |
2.9% |
Induced Labour |
2.9% |
Injection Site Extravasation |
2.9% |
Jaundice |
2.9% |
Maternal Exposure During Pregnancy |
2.9% |
Nasal Congestion |
2.9% |
Nausea |
2.9% |
Oropharyngeal Discomfort |
2.9% |
Oxygen Saturation Decreased |
2.9% |
|
Concomitant |
Drug Use For Unknown Indication |
28.8% |
Product Used For Unknown Indication |
24.3% |
Prophylaxis |
8.7% |
Tumour Pain |
5.6% |
Hypertension |
4.9% |
Multiple Myeloma |
3.5% |
Pain |
2.8% |
Chronic Obstructive Pulmonary Disease |
2.7% |
Constipation |
2.3% |
Inappropriate Antidiuretic Hormone Secretion |
2.3% |
Hiv Infection |
2.2% |
Chemotherapy |
1.7% |
Hyponatraemia |
1.5% |
Nausea |
1.3% |
Insomnia |
1.3% |
Small Cell Lung Cancer Extensive Stage |
1.3% |
Pneumonia |
1.3% |
Thrombosis Prophylaxis |
1.3% |
Drug Toxicity |
1.1% |
Fluid Replacement |
1.1% |
|
Vomiting |
20.0% |
Wrong Technique In Drug Usage Process |
17.6% |
Rapid Correction Of Hyponatraemia |
7.9% |
Intracardiac Thrombus |
6.2% |
Thrombocytopenia |
4.8% |
Visual Field Defect |
4.5% |
Wound Drainage |
4.1% |
Electrocardiogram Qt Corrected Interval Prolonged |
3.8% |
Altered State Of Consciousness |
3.1% |
Psychiatric Symptom |
3.1% |
Subarachnoid Haemorrhage |
3.1% |
Urticaria |
3.1% |
Thrombosis |
2.8% |
Fatigue |
2.4% |
Pneumonia |
2.4% |
Pyrexia |
2.4% |
Wheezing |
2.4% |
Pulmonary Embolism |
2.1% |
Pulmonary Oedema |
2.1% |
Tachycardia |
2.1% |
|
Interacting |
Nuclear Magnetic Resonance Imaging Brain |
100.0% |
|
Transaminases Increased |
100.0% |
|